abs381.txt	background		the	milan	system	for	reporting	salivary	gland	cytopathology	(msrsgc)has	been	proposed	to	standardize	salivary	gland	fine-needle	aspiration	(fna)diagnoses		this	study	assessed	salivary	gland	fna	results	and	risk	of	malignancy(rom)	rates	at	the	university	of	north	carolina	as	well	as	the	interobserverreliability	(ior)	of	the	atypia	of	undetermined	significance	(aus)	and	salivarygland	neoplasm	of	uncertain	malignant	potential	(sump)	categories	methods		the	electronic	medical	record	was	searched	for	fna	cases	from	2010	to2017	with	subsequent	surgical	resections		histologic	diagnosis	was	used	forgold-standard	comparison		the	original	cytologic	results	were	then	converted	intomsrsgc	categories	(nondiagnostic		nonneoplastic		aus		benign	neoplasm		sump	suspicious		and	malignant)		for	the	assessment	of	ior		23	cases	were	selectedwith	enrichment	for	cases	diagnosed	as	aus	(n	=	11)	or	sump	(n	=	9)		six	boardedcytopathologists	and	1	cytopathology	fellow	assessed	representative	slides	andprovided	an	msrsgc	diagnosis	for	each	case		fleiss'	κ	coefficients	werecalculated	to	determine	ior	results		the	rom	was	33%	for	both	aus	and	sump	cases		however		the	risk	ofneoplasia	was	56%	for	aus	cases	and	100%	for	sump	cases		fleiss'	κ	for	the	auscategory	was	0	217	(p	<		05)		and	fleiss'	κ	for	the	sump	category	was	0	024	(p	=	74)	conclusions		in	this	study	assessing	the	ior	of	msrsgc	categories		fair	agreementand	slight	agreement	were	found	for	the	aus	and	sump	categories		respectively	observers	preferentially	used	the	aus	or	benign	neoplasm	category	for	sump	cases	perhaps	because	of	unfamiliarity	with	sump	as	a	diagnostic	option		the	initialadoption	of	a	new	reporting	system	will	require	a	quality	assessment	to	ensurethat	the	system	is	reliable	and	useful	for	clinicians		cancer	cytopathol2018	126	390-6		©	2018	american	cancer	society	
